Diversity and Evolutionary Histories of Human Coronaviruses NL63 and 229E Associated with Acute Upper Respiratory Tract Symptoms in Kuala Lumpur, Malaysia-Reference-Cited by-同舟云学术

Diversity and Evolutionary Histories of Human Coronaviruses NL63 and 229E Associated with Acute Upper Respiratory Tract Symptoms in Kuala Lumpur, Malaysia

Published:2016-05-04 Issue:5 Volume:94 Page:1058-1064
ISSN:0002-9637
Container-title:The American Journal of Tropical Medicine and Hygiene
language:en
Short-container-title:

Author:

Al-Khannaq Maryam Nabiel,Takebe Yutaka,Pang Yong Kek,Oong Xiang Yong,Tee Kok Keng,Ng Kim Tien,Kamarulzaman Adeeba,Hanafi Nik Sherina,Chook Jack Bee

Publisher

American Society of Tropical Medicine and Hygiene

Subject

Virology,Infectious Diseases,Parasitology

Reference45 articles.

1. Cultivation of a novel type of common-cold virus in organ cultures;Tyrrell;Br Med J,1965

2. Growth in suckling-mouse brain of “IBV-like” viruses from patients with upper respiratory tract disease;McIntosh;Proc Natl Acad Sci USA,1967

3. Coronavirus infections in working adults. Eight-year study with 229 E and OC 43;Hendley;Am Rev Respir Dis,1972

4. Coronaviridae;Lai,2006

5. Mosaic structure of human coronavirus NL63, one thousand years of evolution;Pyrc;J Mol Biol,2006

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms of human coronavirus NL63 infection and replication;Virus Research;2023-04

2. Epidemiology of Non-SARS-CoV2 Human Coronaviruses (HCoVs) in People Presenting with Influenza-like Illness (ILI) or Severe Acute Respiratory Infections (SARI) in Senegal from 2012 to 2020;Viruses;2022-12-21

3. Molecular evolution of human coronavirus-NL63, -229E, -HKU1 and -OC43 in hospitalized children in China;Frontiers in Microbiology;2022-11-02

4. Outbreak of acute respiratory disease caused by human adenovirus type 7 and human coronavirus‐229E in Zhejiang Province, China;Journal of Medical Virology;2022-09-10

5. The past, current and future epidemiological dynamic of SARS-CoV-2;Oxford Open Immunology;2022-01-01